Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 769-780 of 1,743
Drug study icon
Recruitment unclearEUCTR 2006-005512-27

A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperac...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
ADHDDrugA study involving a medication or substance.
Countries
France, United Kingdom, Belgium, ...
Sponsor
Eli Lilly and Company
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2020-001424-34

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF SAGE-217 IN THE TREATMENT OF ADULTS WITH SEVERE POSTPARTUM DEPRESSION

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrug
Countries
United Kingdom
Sponsor
Sage Therapeutics, Inc.
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2014-004937-15

A randomized, double-blinded, placebo and lorazepam-controlled, four-way crossover, Phase II study to evaluate the effects of single oral administration of BNC210 on brain activity changes captured...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
AnxietyDrug
Countries
United Kingdom
Sponsor
BIONOMICS LIMITED
Condition
Anxiety
Drug study icon
Recruitment unclearEUCTR 2004-000502-40

A thematic analysis of semi-structured interviews using a phenomenological approach into palliative care patients experiences of change in "fatigue" following treatment with methylphenidate – an ex...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrug
Countries
United Kingdom
Sponsor
Southampton University Hospitals Trust
Condition
Depression
Drug study icon
Recruitment unclearEUCTR 2017-001168-39

An Adaptive, Phase IIb/III, Double-Blind, Randomized, Placebo- Controlled, Multi-Center Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, as an Add-on ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
SchizophreniaDrug
Countries
United Kingdom, Poland
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
Drug study icon
Recruitment unclearEUCTR 2017-001169-26

An Adaptive, Phase IIb/III, Multi-center, Prospective, Randomized, Double-Blind Placebo-controlled Study of the Safety and Efficacy of NaBen® (sodium benzoate), a D-Amino Acid Oxidase Inhibitor, as...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
SchizophreniaDrug
Countries
United Kingdom, Poland
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
Drug study icon
Recruitment unclearEUCTR 2018-001718-13

An Open- Label, Phase 2, Multicenter Feasibility Study if Manualized MDMA-Assisted Psychotherapy with an fMRI sub-study Assessing Changes in Brain Activity in Subjects with Posttraumatic Stress Dis...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
PTSDDrug
Countries
United Kingdom, Czechia, Germany, ...
Sponsor
MAPS Europe B.V.
Condition
PTSD
Drug study icon
Recruitment unclearEUCTR 2019-003623-37

CANnabidiol for Parkinson’s Disease Psychosis

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
SchizophreniaDrug
Countries
United Kingdom
Sponsor
King's College London [...] 1. King's College London 2. South London and Maudsley NHS Foundation Trust
Condition
Schizophrenia
Drug study icon
Recruitment unclearEUCTR 2013-004776-35

Cross-sectional study of 24-hour ambulatory blood pressure measurements and left ventricular mass using echocardiograms in late adolescents and adults with ADHD (ADDUCE protocol WP8 (cardiovascular))

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
ADHDDrug
Countries
United Kingdom
Sponsor
Radboud University Medical Centre Nijmegen
Condition
ADHD
Drug study icon
Recruitment unclearEUCTR 2019-001683-29

Double-Blind, Placebo-Controlled, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-61393215 as Adjunctive Treatment in Adults with Major Depressive Disorder with Anxio...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrug
Countries
United Kingdom
Sponsor
Janssen-Cilag International NV
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.